8-K: Longeveron Inc. Faces Nasdaq Delisting Notice Due to Low Share Price

Longeveron Inc. received a notice from Nasdaq for not meeting the minimum bid price requirement of $1.00 per share, placing the company at risk of delisting.

Summary

• Longeveron Inc. has received a notification from Nasdaq stating that its Class A common stock has failed to maintain a minimum bid price of $1.00 per share.
• The company has been granted an initial 180-day period, until August 31, 2024, to regain compliance with this requirement.
• To regain compliance, the stock price must close at or above $1.00 for at least ten consecutive business days.
• If the stock price falls to $0.10 or less for ten consecutive trading days, Nasdaq may issue a Staff Determination Letter, potentially leading to immediate suspension and delisting.
• Longeveron may be eligible for an additional 180-day compliance period if it meets other listing requirements, excluding the minimum bid price.
• The company is considering options to regain compliance, including a potential reverse stock split, which was authorized by shareholders at a special meeting on February 21, 2024.
• The board has not yet determined the specific ratio for the reverse stock split.
• There is no guarantee that Longeveron will regain compliance with the minimum bid price requirement or other Nasdaq listing rules.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice and the uncertainty surrounding the company's ability to regain compliance. The potential reverse stock split adds further uncertainty.

Positives

• Longeveron has been granted a 180-day period to regain compliance with Nasdaq's minimum bid price requirement.
• The company has the option to pursue a reverse stock split to increase its share price.
• The company may be eligible for an additional 180-day compliance period if it meets other listing requirements.

Negatives

• Longeveron's stock price has fallen below the $1.00 minimum bid price required by Nasdaq.
• The company faces the risk of delisting if it cannot regain compliance by the deadline.
• If the stock price falls to $0.10 or less for ten consecutive trading days, Nasdaq can issue a Staff Determination Letter, potentially leading to immediate suspension and delisting.
• There is no guarantee that the company will be able to regain compliance.

Risks

• The company faces the risk of being delisted from the Nasdaq Capital Market if it cannot regain compliance with the minimum bid price requirement.
• The reverse stock split may not be sufficient to raise the stock price above $1.00.
• The company's stock price could continue to decline, potentially leading to further delisting risks.
• There is no guarantee that the company will be able to meet all other listing requirements to qualify for an additional compliance period.

Future Outlook

The company intends to monitor the stock price and assess its options to regain compliance, including a potential reverse stock split, but there is no guarantee of success.

Management Comments

• The company intends to monitor the closing bid price of the Common Stock and assess its available options in order to regain compliance with the Minimum Bid Price Requirement and continue listing on the Nasdaq Capital Market, including a potential reverse stock split of its Common Stock.

Industry Context

This announcement is not uncommon for companies that have experienced a decline in their stock price. Many companies in the biotech sector, especially those in the development stage, can face similar challenges with maintaining listing requirements.

Comparison to Industry Standards

• Many small-cap biotech companies face similar challenges in maintaining their stock price above the minimum bid price required by exchanges like Nasdaq.
• Companies like Cassava Sciences (SAVA) and Ocugen (OCGN) have also faced similar delisting risks in the past due to low stock prices.
• Reverse stock splits are a common strategy used by companies in this situation to increase their share price and regain compliance.
• The success of these strategies varies, and many companies ultimately fail to regain compliance and are delisted.

Stakeholder Impact

• Shareholders face the risk of losing their investment if the company is delisted.
• Employees may experience uncertainty about the company's future.
• The company's reputation may be negatively impacted.

Next Steps

• The company will monitor the closing bid price of its common stock.
• The company will assess its options to regain compliance with the minimum bid price requirement.
• The company may implement a reverse stock split.
• The company will need to meet all other listing requirements to qualify for an additional compliance period.

Key Dates

Keywords

delisting, Nasdaq, minimum bid price, reverse stock split, compliance, stock price, LGVN